Source comparison
Peptides for Ligament Repair: Comparison of Mechanisms
BPC-157 VEGF upregulation, angiogenesis promotion Inflammation → Proliferation 200–400 mcg/kg (animal models) 21–28 days at 4°C 62% greater collagen density at injury site (14 days post-injury, rat model) TB-500 (Thymosin Beta-4 Fragment) Actin binding, fibrob
This comparison does not assign a generated winner or score.
- BPC-157
- VEGF upregulation, angiogenesis promotion
- Inflammation → Proliferation
- 200–400 mcg/kg (animal models)
- 21–28 days at 4°C
- 62% greater collagen density at injury site (14 days post-injury, rat model)
- TB-500 (Thymosin Beta-4 Fragment)
- Actin binding, fibroblast migration
- Proliferation → Remodeling
- 2–10 mg total dose (animal models)
- 28–35 days at 4°C
- 40% reduction in inflammatory markers (IL-6, TNF-alpha) within 7 days
- GHK-Cu
- MMP modulation, collagen remodeling
- Remodeling → Maturation
- 1–3 mg (topical/local administration)
- 14–21 days at 4°C (copper oxidation risk)
- Balanced MMP-2/MMP-9 expression, improved collagen alignment